Table 5.
Distributions of E-cadherin immunoexpression patterns among the control and study groups
| IE patterns | Group | Total | χ2 | P | |||
|---|---|---|---|---|---|---|---|
| Normal | WDSCC | MDSCC | PDSCC | ||||
| C (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 17 (100.0) | 17 (25.4) | 134.00 | <0.0001 |
| M (%) | 10 (100.0) | 20 (100.0) | 0 (0.0) | 0 (0.0) | 30 (44.8) | ||
| MC (%) | 0 (0.0) | 0 (0.0) | 20 (100.0) | 0 (0.0) | 20 (29.9) | ||
| Total (%) | 10 (100.0) | 20 (100.0) | 20 (100.0) | 17 (100.0) | 67 (100.0) | ||
WDSCC: Well-differentiated squamous cell carcinoma; MDSCC: Moderately differentiated squamous cell carcinoma; PDSCC: Poorly differentiated squamous cell carcinoma; C: Cytoplasmic; M: Membranous; MC: Membranous-Cytoplasmic